Interleukin-2 Therapy of Cancer Cited by

Fol. Biol. 2004, 50, 120-130

https://doi.org/10.14712/fb2004050030120

Jan Bubeník

Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic

Li Jiapeng, Huang Xiaojun, Wang Qian, Jing Shan, Jiang Hao, Wei Zhongna, Zang Yannan, Liu Yang, Zhao Libo, Fang Yi, Feng Wanyu: Pharmacokinetic Properties and Safety Profile of Histamine Dihydrochloride Injection in Chinese Healthy Volunteers: A Phase I, Single-center, Open-label, Randomized Study. Clinical Therapeutics 2015, 37, 2352. <https://doi.org/10.1016/j.clinthera.2015.07.017>
Bahrambeigi Vahid, Ahmadi Nafiseh, Salehi Rasoul, Javanmard Shaghayegh Haghjooy: Genetically Modified Murine Adipose-Derived Mesenchymal Stem Cells Producing Interleukin-2 Favor B16F10 Melanoma Cell Proliferation. Immunological Investigations 2015, 44, 216. <https://doi.org/10.3109/08820139.2014.988719>
Shen Yizhen, Liu Yi, Liu Shaoge, Zhang Aimin: The Association Between -330T/G Polymorphism of Interleukin 2 Gene and Bladder Cancer. DNA and Cell Biology 2012, 31, 983. <https://doi.org/10.1089/dna.2011.1476>